Virax Biolabs Group Ltd (VRAX) Receivables (2021)
Virax Biolabs (VRAX) posted Receivables of $928.0 for Q1 2021.
Virax Biolabs (VRAX) has 1 years of Receivables data on file, last reported at $928.0 in Q1 2021.
- In Q1 2021, Receivables changed N/A year-over-year to $928.0; the TTM figure through Mar 2021 stood at $928.0 (changed N/A YoY), while the FY2021 annual figure was $928.0, changed N/A from the prior year.
- Receivables steadied at $928.0 in Q1 2021.
- Across five years, Receivables topped out at $928.0 in Q1 2021 and bottomed at $928.0 in Q1 2021.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 928.00 |